Palliative care in multiple sclerosis and motor neurone disease

British Journal of Hospital Medicine

Volumn 71, Issue 1, 2010, Pages 21-25

  Barnes, Julia ^a   Campbell, Colin ^a  

^a St Catherine's Hospice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; HEALTH CARE DELIVERY; HUMAN; MIDDLE AGED; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; NEEDS ASSESSMENT; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; STANDARD; TERMINAL CARE;

ADULT; AGED; HEALTH SERVICES ACCESSIBILITY; HUMANS; MIDDLE AGED; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; NEEDS ASSESSMENT; PALLIATIVE CARE; QUALITY OF LIFE; TERMINAL CARE; YOUNG ADULT;

EID: 77952305822     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2010.71.1.45968     Document Type: Article

References (18)

1. Beard S, Hunn A, Wight J (2003) Treatment for spasticity and pain in MS- a systematic review. Health Technology Assessment 7(40).
2. Bobholz J, Rao S (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Cure Opin Neurol 16: 283-8.
3. Bourke S, Tomlinson M, Williams T, Bullock R, Shaw P, Gibson G (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5: 140-7.
4. British Medical Association (2007) Withholding and Withdrawing Life-prolonging Medical Treatment; Guidance for decision making. 3rd cdn. Blackwell, Oxford.
5. Department of Health Long-term Conditions National Service Framework Team (2005) National Service Framework for Long Term Conditions. Department of Health, London.
6. Edmonds P, Vivat B, Burman R, Silber E, Higginson I (2007) Loss and change: experiences of people severely affected by multiple sclerosis. Palliat Med 21: 101-7.
7. Ganzini L, Johnston W, Hoffman W (1999) Correlates of suffering in amyotrophic lateral sclerosis. Neurology 52(7): 1434-40.
8. Ghaffar O, Feinstein A (2007) The neuropsychiatry of multiple sclerosis: a review of recent developments, Curr Opin Psych 20: 278-85.
9. Higginson I, Hart S, Silber E, Burman R, Edmonds P (2006) Symptom prevalence and severity in people severely affected by multiple sclerosis.J Pall Care 22(3): 158-65.
10. Hirst C, Swingler R, Compston D, Ben-Shlomo Y, Robertson N (2008) Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry 79: 1016-21.
11. Kalia L, O'Connor P (2005) Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Multiple Sclerosis 11:322-7.
12. McDermott C, Shaw P (2008) Diagnosis and management of motor neurone disease. BMJ 336: 658-62.
13. Massman P, Sims J, Cooke N, Haverkamp L, Appel V, Appel S (1996) Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 61: 450-5.
14. National Council for Palliative Care (2008) The Mental Capacity Act in Practice: Guidance for end of life care. National Council for Palliative Care, London.
15. National Institute for Clinical Excellence (2003) Management of Multiple Sclerosis in primary and secondary care. Clinical Guideline 8. National Institute for Clinical Excellence, London.
16. Newrick P, Langton-Hewer R (1985) Pain in motor neurone disease. J Neurol Neurosurg Psychiatry 48: 838-40.
17. O'Brien T, Kelly M, Saunders C (1992) Motor neurone disease: a hospice perspective. BMJ 304: 471-3.
18. Oliver D (1998) Opioid medication in the palliative care of motor neurone disease. Palliat Med 12: 113-15.